Last updated on July 2010

A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis

Brief description of study

This is a phase II double blind multicenter randomized placebo-controled clinical study aimed to find out whether treatment with Filtrum-STI (orally administered 0,4g tablets) is safe and effective in children with viral gastroenteritis. Filtrum-STI (lignin hydrolytic) is a drug with a high absorbing ability, that binds and eliminates toxins, pathogenic microorganisms and viruses. Filtrum-STI is inoffensive for mucous membranes, enhances colonic propulsion and improves its natural microflora. The drug is not toxic and well combines with other medication

Clinical Study Identifier: NCT01113346


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Larisa Titova, MD, PhD

Arhangelsk Regional Children's Clinical Hospital named after P.G. Vizshletsov
Arhangelsk, Russian Federation
  Connect »

Elena Meskina, MD, DrSc

St. Vladimir Children's Moscow Clinical Hospital
Moscow, Russian Federation
  Connect »